s.cabrera
TL2 Moderator · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 25 August 2025 · last posted 19h
89 posts, newest first. Showing up to 150.
-
When a dose reduction is the correct response to a side effect Replied, post #43 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #94 · Compounds › Retatrutide · 26 Jul 2026 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #86 · Practice › Interactions · 25 Jul 2026 · 10 likes I read post #84 twice before replying, because I had assumed the opposite. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…
-
Cleaning a self-reported dataset and what you throw away — what changed since Replied, post #2 · Data & Tools › Datasets · 18 Jul 2026 · 2 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Seven-day rolling means and why weekly readings mislead Replied, post #40 · Outcomes › Progress reports · 16 Jul 2026 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #51 · Evidence › Journal club · 11 Jul 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #14 · Clinical › Prescriber conversations · 7 Jul 2026 · 4 likes I read post #12 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #101 · Start Here › How to Ask · 6 Jul 2026 · 3 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #3 · Analytics › Impurities & related substances · 5 Jul 2026 · 17 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #101 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 3 likes post #100 is right about the mechanism and I think understates the practical bit. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #3 · Pharmacology › Receptor biology · 23 Jun 2026 · 17 likes This follows post #2 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
What to include when your question involves a chromatogram — one year on Replied, post #48 · Start Here › How to Ask · 23 Jun 2026 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Search filters: what is missing Replied, post #72 · Meta › Site feedback · 22 Jun 2026 · 10 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Racemisation and why it is invisible to a mass measurement Replied, post #118 · Analytics › Impurities & related substances · 15 Jun 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #66 · Safety › Contraindications · 8 Jun 2026 · 17 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #15 · Analytics › HPLC & UHPLC · 8 Jun 2026 · 0 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Cleaning a self-reported dataset and what you throw away Started this topic · Data & Tools › Datasets · 28 May 2026 · 37 likes Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. A documentation question rather than an…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #13 · Documentation › Doc review · 27 May 2026 · 25 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Tracking a shortage from primary sources rather than rumour Replied, post #21 · Access › Shortages · 24 May 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #51 · Compounds › Tirzepatide · 14 May 2026 · 4 likes post #50 answers the question as asked. The question underneath it is different. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #2 · Documentation › Doc review · 2 May 2026 · 14 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
A site rotation scheme that is easy enough to actually follow Replied, post #47 · Practice › Administration · 23 Apr 2026 · 17 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Revisiting: Spike-and-recover accuracy for a peptide assay Started this topic · Analytics › Method validation · 9 Apr 2026 · 7 likes Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I would like to understand what this…
-
Follow-up: State-level differences that actually matter Replied, post #22 · Regional › North America · 5 Apr 2026 · 2 likes Picking up post #19: that is the part I would want checked first. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #74 · Sourcing › Regulatory · 2 Apr 2026 · 4 likes On post #70 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #9 · Practice › Administration · 29 Mar 2026 · 23 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #48 · Compounds › Tirzepatide · 17 Mar 2026 · 27 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
CJC-1295 with and without DAC: what the modification does Replied, post #10 · Compounds › Secretagogues & GH axis · 9 Mar 2026 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only…
-
Grapefruit: why this class is not the class that cares Replied, post #21 · Practice › Interactions · 8 Mar 2026 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A site rotation scheme that is easy enough to actually follow Replied, post #7 · Practice › Administration · 18 Feb 2026 · 6 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Replied, post #3 · Compounds › Semaglutide · 2 Feb 2026 · 12 likes Coming back to the opening post, because the follow-up matters more than the original answer. On alcohol: the labelling does not contraindicate it, but it raises…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #3 · Compounds › Repair & healing peptides · 25 Jan 2026 · 11 likes post #2 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #73 · Access › International · 25 Jan 2026 · 2 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #67 · Practice › Side effects · 19 Jan 2026 · 27 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #44 · Meta › Site feedback · 14 Jan 2026 · 27 likes post #43 answers the question as asked. The question underneath it is different. Community norms: if you think a norm has drifted or is not being followed consistently,…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #36 · Practice › Side effects · 5 Jan 2026 · 0 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #8 · marked as the solution · Data & Tools › Datasets · 24 Dec 2025 · 8 likes Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
The decimal-point error, and the habit that catches it Replied, post #116 · Practice › Reconstitution · 18 Dec 2025 · 1 like Picking up post #113: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
Search filters: what is missing Replied, post #5 · Meta › Site feedback · 24 Nov 2025 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Display issues: broken layouts, images not loading, text overlapping — report with the browser…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #50 · Safety › Adverse events · 24 Oct 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #18 · Data & Tools › Calculators · 13 Oct 2025 · 2 likes Coming back to post #16, because the follow-up matters more than the original answer. Offline use: all calculators are written in JavaScript and can be downloaded and…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #2 · Data & Tools › Calculators · 9 Oct 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Realistic expectations for strength while losing weight quickly Replied, post #26 · Nutrition & Training › Resistance training · 6 Oct 2025 · 14 likes I read post #24 twice before replying, because I had assumed the opposite. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #65 · Documentation › Doc review · 28 Sep 2025 · 3 likes post #64 answers the question as asked. The question underneath it is different. New maintainer recruitment: if a page's maintainer is inactive and updates are needed,…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #15 · Documentation › Doc review · 21 Sep 2025 · 22 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Payment method and the leverage it gives you, ranked Replied, post #38 · Sourcing › Payments · 19 Sep 2025 · 20 likes Picking up post #35: that is the part I would want checked first. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #115 · Evidence › Journal club · 26 Aug 2025 · 11 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #8 · Meta › Announcements · 25 Aug 2025 · 12 likes Coming back to post #6, because the follow-up matters more than the original answer. Staff-only posts: some announcements are visible only to staff (concerning internal…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 24 Aug 2025 · 16 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Publishing an inconvenient result: a case study Replied, post #71 · Sourcing › Independent verification · 23 Aug 2025 · 0 likes Coming back to post #69, because the follow-up matters more than the original answer. Cost and turnaround: different services have different pricing and turnaround…
-
When a preprint is the best available evidence and we say so Replied, post #87 · Evidence › Preprints · 23 Aug 2025 · 4 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
What pooling buys you and what it destroys Replied, post #8 · Evidence › Meta-analyses · 21 Aug 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #50 · Evidence › Journal club · 17 Aug 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Are there stupid questions here? A staff answer, at length Replied, post #79 · Start Here › Welcome · 16 Aug 2025 · 16 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Revisiting: German, French and Dutch differences, compared Replied, post #58 · Regional › European Union · 13 Aug 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Travel coolers and how long they really hold Replied, post #31 · Devices › Cold chain · 3 Aug 2025 · 1 like Coming back to post #29, because the follow-up matters more than the original answer. Assessing an excursion: if a package sat at room temperature for a time, visual…
-
Managing an unplanned gap in supply — what changed since Replied, post #29 · Access › Shortages · 2 Aug 2025 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Micronutrient status when intake falls substantially Replied, post #19 · Clinical › Bloodwork · 23 Jul 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #8 · Wellbeing › Mental health · 20 Jul 2025 · 7 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Regression to the mean in progress reports Replied, post #33 · Research Methods › Statistics · 16 Jul 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a documentation review can and cannot tell you Replied, post #20 · Sourcing › Independent verification · 1 Jul 2025 · 8 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Repeatability versus intermediate precision Replied, post #86 · Analytics › Method validation · 28 Jun 2025 · 0 likes post #85 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #140 · Compounds › Cagrilintide & amylin analogues · 24 Jun 2025 · 10 likes This follows post #137 rather than contradicting it. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #44 · Evidence › Journal club · 18 Jun 2025 · 16 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
About the Contraindications category Replied, post #9 · Safety › Contraindications · 1 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Documentation that appears only after payment Replied, post #87 · Sourcing › Red flags · 17 May 2025 · 28 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #10 · Practice › Dosing & titration · 3 May 2025 · 18 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #34 · Sourcing › Independent verification · 1 May 2025 · 14 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Certificates issued by the seller versus by a laboratory Replied, post #66 · Analytics › COA interpretation · 28 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Albumin binding and how it produces a long half-life Replied, post #28 · Pharmacology › Pharmacokinetics · 23 Apr 2025 · 1 like Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
When "no data" is the complete and final answer Replied, post #152 · Compounds › Other compounds · 18 Apr 2025 · 18 likes On post #148 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the…
-
Deamidation and the close-eluting pair it produces Replied, post #21 · Analytics › Impurities & related substances · 7 Apr 2025 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #121 · Compounds › Semaglutide · 28 Mar 2025 · 9 likes On post #117 — agreed on the reasoning, with one qualification. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #46 · Access › Pricing · 27 Mar 2025 · 0 likes Picking up post #43: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #16 · Practice › Dosing & titration · 25 Mar 2025 · 28 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Retatrutide dose escalation in the published trials Replied, post #44 · Compounds › Retatrutide · 24 Mar 2025 · 8 likes I read post #42 twice before replying, because I had assumed the opposite. Retatrutide is investigational. Anything obtained outside a trial is by definition…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #16 · Sourcing › Vendor reports · 20 Mar 2025 · 19 likes Worth separating two things that post #12 runs together. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #37 · Evidence › Journal club · 11 Mar 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #107 · Compounds › Semaglutide · 15 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #5 · Start Here › Welcome · 28 Jan 2025 · 0 likes Worth separating two things that the opening post runs together. On the reading order question specifically: start with the how-to-ask materials in this category, then…
-
Identical chromatograms across two different lots Replied, post #81 · Sourcing › Red flags · 25 Jan 2025 · 32 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
[2026 update] New subcategory: rationale and scope Replied, post #110 · Meta › Announcements · 1 Jan 2025 · 9 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #72 · Compounds › Tirzepatide · 6 Dec 2024 · 21 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Transporting a vial for a weekend away Replied, post #38 · Practice › Storage & stability · 7 Nov 2024 · 33 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Second pass at: Reimbursement variation across member states Replied, post #18 · Regional › European Union · 10 Oct 2024 · 31 likes Picking up post #15: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
The mass-error checker and its intended scope Replied, post #161 · Data & Tools › Calculators · 28 Jul 2024 · 8 likes Picking up post #158: that is the part I would want checked first. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #117 · Compounds › Retatrutide · 24 Jul 2024 · 3 likes I read post #115 twice before replying, because I had assumed the opposite. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #22 · Practice › Dosing & titration · 7 Jul 2024 · 12 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Assessing a warm arrival: the decision process — one year on Replied, post #87 · Sourcing › Logistics · 31 May 2024 · 8 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…